Profile data is unavailable for this security.
About the company
Epigenomics AG is a Germany-based molecular diagnostics company focused on blood-based detection, prognosis and monitoring of cancers using deoxyribonucleic acid (DNA) methylation technology. It develops and commercializes blood-based diagnostic products across multiple cancer indications. The Company's main product is Epi proColon, a blood test for colorectal cancer screening. Along with the blood-based tests the Company offers services related to research, product development, regulatory approval and manufacturing of in-vitro diagnostic (IVD) products. It also offers Epi proLung, a blood-based test that detects the presence of lung cancer in blood plasma. The Company is present in Europe and the United States.
- Revenue in EUR (TTM)448.00k
- Net income in EUR-16.29m
- Incorporated2000
- Employees18.00
- LocationEpigenomics AGGeneststrasse 5BERLIN 10829GermanyDEU
- Phone+49 30243450
- Fax+49 3 024345555
- Websitehttps://www.epigenomics.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oxurion NV | 263.00k | -18.97m | 1.01m | 20.00 | -- | -- | -- | 3.84 | -0.023 | -0.023 | 0.0002 | -0.0038 | 0.0284 | 63.60 | 0.1253 | 13,150.00 | -204.59 | -84.30 | -- | -118.70 | 39.54 | 48.90 | -7,212.55 | -2,008.99 | 0.1398 | -1.75 | -- | -- | -55.80 | -45.20 | 40.13 | -- | -65.17 | -- |
Diagonal Bio AB | 1.98k | -1.01m | 1.07m | 4.00 | -- | 0.0959 | -- | 538.25 | -0.1982 | -0.1982 | 0.0004 | 0.3221 | 0.0007 | -- | 2.00 | 5,750.00 | -37.35 | -- | -44.49 | -- | -41,604.35 | -- | -50,769.57 | -- | 0.5105 | -104.20 | -- | -- | -88.67 | -- | 27.75 | -- | -- | -- |
Rapid Nutrition PLC | 1.82m | -1.45m | 1.20m | 9.00 | 39.18 | 541.70 | -- | 0.6627 | 0.0017 | 0.0017 | 0.0034 | 0.0001 | 1.84 | 3.90 | 3.05 | 201,766.30 | -146.98 | -- | -1,011.07 | -- | 71.47 | -- | -79.74 | -- | 1.07 | -- | 0.7674 | -- | -1.50 | -- | -1,090.33 | -- | -- | -- |
XP Chemistries AB | 57.19k | -692.65k | 1.40m | 2.00 | -- | 0.6328 | -- | 24.49 | -0.2846 | -0.2846 | 0.0213 | 0.275 | 0.023 | 0.2084 | 5.99 | 331,845.00 | -27.79 | -- | -29.36 | -- | 50.57 | -- | -1,211.24 | -- | 5.79 | -- | 0.00 | -- | -37.14 | -- | -1.55 | -- | -- | -- |
Epigenomics AG | 448.00k | -16.29m | 1.42m | 18.00 | -- | 0.6705 | -- | 3.16 | -19.49 | -19.49 | 0.536 | 2.24 | 0.0361 | 2.73 | 3.34 | 13,176.47 | -131.18 | -65.64 | -167.31 | -83.85 | 76.56 | 89.26 | -3,636.16 | -548.19 | 1.93 | -- | 0.1572 | -- | -92.18 | -23.61 | -395.22 | -- | 44.06 | -- |
Aptahem AB | 2.76k | -957.50k | 1.42m | -- | -- | 0.128 | -- | 513.40 | -0.0497 | -0.0497 | 0.0001 | 0.2266 | 0.0005 | -- | 0.0738 | -- | -16.76 | -39.26 | -19.47 | -44.19 | 4,623.59 | -- | -34,727.72 | -- | -- | -10.17 | 0.0847 | -- | -- | -- | -25.36 | -- | -- | -- |
Private Rented Sector SA | 47.02k | 6.40k | 1.46m | -- | 228.27 | -- | 66.23 | 31.05 | 0.0206 | 0.0206 | 0.1514 | -0.035 | 1.79 | -- | 2.20 | -- | 24.28 | 1,266.23 | -- | -- | 23.89 | -1,935.55 | 13.60 | 2,755.44 | -- | -- | -- | -- | -- | -- | -66.26 | -- | -- | -- |
Circio Holding ASA | 10.59k | -9.53m | 1.61m | 11.00 | -- | -- | -- | 151.70 | -16.75 | -16.75 | 0.0181 | -12.89 | 0.0019 | -- | 0.0072 | 11,181.82 | -172.29 | -46.58 | -- | -53.40 | -- | -- | -90,029.27 | -6,902.00 | -- | -9.82 | 7.73 | -- | -98.77 | 35.43 | 74.42 | -- | -- | -- |
Asarina Pharma AB (publ) | 0.00 | -1.11m | 1.66m | -- | -- | 12.34 | -- | -- | -0.5704 | -0.5704 | 0.00 | 0.069 | 0.00 | -- | -- | -- | -113.04 | -61.28 | -150.47 | -71.81 | -- | -- | -- | -- | -- | -- | 0.3902 | -- | -- | -- | 2.79 | -- | -- | -- |
Oxford Cannabinoid Tchnlgs Hldngs PLC | 0.00 | -4.96m | 1.72m | 7.00 | -- | 0.6649 | -- | -- | -0.0044 | -0.0044 | 0.00 | 0.002 | 0.00 | -- | -- | 0.00 | -82.98 | -56.41 | -104.70 | -66.13 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -26.16 | -- | -- | -- |
Peptonic Medical AB | 3.36m | -3.90m | 1.72m | 37.00 | -- | 0.3101 | -- | 0.5121 | -0.0325 | -0.0325 | 0.0288 | 0.0419 | 0.4185 | 1.42 | 5.49 | 1,055,432.00 | -48.49 | -46.02 | -61.53 | -60.85 | 44.34 | 54.26 | -115.88 | -139.38 | 0.5002 | -140.41 | 0.2084 | -- | -14.93 | 149.65 | -15.55 | -- | 27.15 | -- |
AegirBio AB | 8.53k | -31.62m | 1.73m | 1.00 | -- | 2.25 | -- | 203.35 | -24.31 | -24.31 | 0.0047 | 0.2895 | 0.0004 | 2.00 | 0.0207 | -- | -163.02 | -- | -171.79 | -- | -24,398.99 | -- | -370,710.10 | -- | 2.53 | -27.27 | 0.8209 | -- | -87.16 | -- | -292.98 | -- | -- | -- |
Nuformix PLC | 0.00 | -511.36k | 1.77m | 2.00 | -- | 0.3282 | -- | -- | -0.0006 | -0.0006 | 0.00 | 0.0056 | 0.00 | -- | -- | -- | -9.50 | -- | -9.95 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
Lidds AB | 0.00 | -3.46m | 1.82m | 2.00 | -- | 0.7585 | -- | -- | -0.8316 | -0.8316 | 0.00 | 0.2037 | 0.00 | -- | -- | 0.00 | -184.54 | -46.33 | -274.93 | -51.61 | -- | -1,934.24 | -- | -3,076.68 | -- | -- | 0.00 | -- | -100.00 | -- | -9.08 | -- | -- | -- |
Theravet SA | -100.00bn | -100.00bn | 1.84m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |